F Lhermitte, M Peterfalvi, R Marteau, J Gazengel, M Serdaru. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » 5-Hydroxytryptophan/pharmacologyAlcohols/pharmacologyAnticonvulsants/pharmacologyBenzoates/pharmacologyCarbamazepine/pharmacologyChlorpromazine/pharmacologyDiazepam/pharmacologyDibenzazepines/pharmacologyDopamine/pharmacologyErgotamine/pharmacologyFemaleHaloperidol/pharmacologyHumansHypoxia, Brain/complicationsMethotrimeprazine/pharmacologyMethyldopa/pharmacologyMethysergide/pharmacologyMiddle AgedMyoclonus/drug therapyNorepinephrine/pharmacologyPhenobarbital/pharmacologyPyrrolidines/pharmacologyStereotaxic TechniquesSulfonamides/pharmacologyTranquilizing Agents/pharmacologyTrihexyphenidyl/pharmacology
Substances: See more » AlcoholsAnticonvulsantsBenzoatesDibenzazepinesPyrrolidinesSulfonamidesTranquilizing AgentsCarbamazepineMethyldopaTrihexyphenidylMethotrimeprazine5-HydroxytryptophanHaloperidolErgotamineDiazepamChlorpromazineDopamineNorepinephrineMethysergidePhenobarbital
Year: 1971 PMID: 4935256
Source DB: PubMed Journal: Rev Neurol (Paris) ISSN: 0035-3787 Impact factor: 2.607